ZNF780A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.523600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.596200E-01
Normal-vs-Stage2
2.539400E-01
Normal-vs-Stage3
6.157900E-02
Normal-vs-Stage4
4.598000E-01
Stage1-vs-Stage2
1.960970E-01
Stage1-vs-Stage3
3.392200E-02
Stage1-vs-Stage4
4.501600E-01
Stage2-vs-Stage3
1.538640E-01
Stage2-vs-Stage4
8.748600E-01
Stage3-vs-Stage4
1.203630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.710000E-01
Normal-vs-AfricanAmerican
2.075000E-01
Normal-vs-Asian
2.190400E-01
Caucasian-vs-AfricanAmerican
8.998000E-01
Caucasian-vs-Asian
9.770800E-01
AfricanAmerican-vs-Asian
8.447400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.579600E-01
Normal-vs-Female
1.258430E-01
Male-vs-Female
5.111000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.596200E-01
Normal-vs-Age(41-60Yrs)
6.420000E-01
Normal-vs-Age(61-80Yrs)
9.383600E-02
Normal-vs-Age(81-100Yrs)
5.070200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.621000E-04
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.654500E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.320800E-03
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.135960E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.168100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.387400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.822000E-02
Normal-vs-Daily Drinker
1.176630E-01
Normal-vs-Weekly Drinker
4.139700E-02
Normal-vs-Occasional Drinker
2.443600E-01
Normal-vs-Social Drinker
7.126000E-01
Non Drinker-vs-Daily Drinker
6.667400E-01
Non Drinker-vs-Weekly Drinker
7.575400E-01
Non Drinker-vs-Occasional Drinker
1.479750E-01
Non Drinker-vs-Social Drinker
2.168800E-01
Daily Drinker-vs-Weekly Drinker
4.755400E-01
Daily Drinker-vs-Occasional Drinker
3.017400E-01
Daily Drinker-vs-Social Drinker
3.117200E-01
Weekly Drinker-vs-Occasional Drinker
8.152100E-02
Weekly Drinker-vs-Social Drinker
1.641630E-01
Occasional Drinker-vs-Social Drinker
6.406400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.262300E-02
Normal-vs-Grade 2
8.282400E-02
Normal-vs-Grade 3
8.737500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.944200E-01
Grade 1-vs-Grade 3
4.111000E-01
Grade 1-vs-Grade 4
4.262300E-02
Grade 2-vs-Grade 3
7.465200E-01
Grade 2-vs-Grade 4
8.282400E-02
Grade 3-vs-Grade 4
8.737500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.195700E-02
Normal-vs-NonDiabetic
2.695600E-01
Diabetic-vs-NonDiabetic
2.198600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.666000E-01
Normal-vs-NoPancreatitis
2.210200E-01
Pancreatitis-vs-NoPancreatitis
7.872100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.008000E-01
Normal-vs-N1
2.786000E-01
N0-vs-N1
7.815200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.988400E-01
Normal-vs-TP53-NonMutant
6.832400E-01
TP53-Mutant-vs-TP53-NonMutant
5.204400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
